|
|
| | 7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione Basic information |
| Product Name: | 7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | | Synonyms: | TOSLAB 870935;7-[(4-fluorophenyl)methyl]-8-{[2-(1H-indol-3-yl)eth yl]amino}-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purin e-2,6-dione;1H-Purine-2,6-dione, 7-[(4-fluorophenyl)methyl]-3,7-dihydro-8-[[2-(1H-indol-3-yl)ethyl]amino]-1,3-dimethyl-;PSB-KK1445;7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione | | CAS: | 885896-54-8 | | MF: | C24H23FN6O2 | | MW: | 446.48 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione Structure](StructureFile/ChemBookStructure9/GIF/CB6700702.gif) |
| | 7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione Chemical Properties |
| solubility | DMSO: Sparingly soluble: 1-10 mg/ml | | form | Solid | | color | White to off-white |
| | 7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione Usage And Synthesis |
| Uses | PSB-KK1445 is a potent and selective GPR18 agonist with EC50s of 45.4 nM and 124 nM for human and mouse GPR18, respectively. PSB-KK1445 displays >200-fold selectivity versus both CB receptor subtypes, GPR55, and GPR183[1]. | | References | [1] Andhika B Mahardhika, et al. Potent, Selective Agonists for the Cannabinoid-like Orphan G Protein-Coupled Receptor GPR18: A Promising Drug Target for Cancer and Immunity. J Med Chem. 2024 Jun 27;67(12):9896-9926. DOI:10.1021/acs.jmedchem.3c02423 |
| | 7-(4-Fluorobenzyl)-8-{[2-(1H-indol-3-yl)ethyl]amino}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione Preparation Products And Raw materials |
|